HIGHLIGHTS
- who: Koichiro Inaki et al. from the Department, Daiichi Sankyo RD Novare Co, Ltd, Tokyo, Japan, Pathology, Universitau0308tsspital Basel have published the Article: Pan-cancer gene expression analysis of tissue microarray using EdgeSeq oncology biomarker panel and a cross-comparison with HER2 and HER3 immunohistochemical analysis, in the Journal: PLOS ONE of 31/03/2022
- what: The aim of this analysis was to validate the TMA EdgeSeq platform against RNAseq Once validated, this platform was used to assess gene signature patterns based on pathological cancer types/subtypes present within the TMA data set, including several . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.